# A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-08-24

Status: RECRUITING · Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. · Condition: SCLC, Extensive Stage

- Company: MediLink Therapeutics (Suzhou) Co., Ltd.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07739758

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.